Stryker is a global medical technology company founded in 1941 that develops and commercialises products and services across three main segments: MedSurg, Neurotechnology, and Orthopaedics. The company's portfolio spans acute care, surgical technologies, endoscopy, joint replacement, neurovascular systems, and sports medicine solutions. With operations in 75 countries and products reaching more than 150 million patients annually, Stryker operates at substantial scale in the medical device industry.
The company generated $22.6 billion in global sales in 2024 and invested $1.5 billion in research and development that year. Stryker holds a significant intellectual property position with 14,200 patents across its product lines. Its technical capabilities span medical device design and manufacturing, surgical innovation, neurotech applications, and orthopaedic engineering.
Stryker describes its organisational culture as centred on integrity, accountability, people, and performance. The company states that it empowers employees to contribute meaningfully to healthcare outcomes and maintains that innovation flourishes within its environment. The organisation positions itself as an industry leader that has grown from a small manufacturer into a global powerhouse across multiple medical technology disciplines.
